Relapsed Acute Myeloid Leukemia With Isolated Conjugated Hyperbilirubinemia Secondary to High-Dose Cytarabine Therapy

被引：0
|
作者：
Akpara, Ugochukwu [1 ]
Choi, Anthony J. [2 ]
Wan, David [3 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, Brooklyn, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S2562
引用
收藏
页码：S1348 / S1348
页数：1
相关论文
共 50 条
  • [1] Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia
    Deisseroth, Albert
    Farrell, Ann
    Justice, Robert
    Kane, Robert
    Sridhara, Rajeshwari
    Chen, Huanyu
    He, Kun
    Pazdur, Richard
    BLOOD, 2010, 115 (02) : 430 - 430
  • [2] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    BLOOD, 1996, 88 (02) : 754 - 754
  • [3] A clinical report on high-dose cytarabine therapy for children with acute myeloid leukemia
    Wu, Ziliang
    Wu, Zelin
    Zou, Yawei
    Guan, Jingming
    Wu, Shangzhi
    Chen, Dehui
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (05)
  • [4] Acute Hepatotoxicity After High-Dose Cytarabine for the Treatment of Relapsed Acute Myeloid Leukemia: A Case Report
    Fu, Samuel H.
    Flannery, Alexander H.
    Bastin, Melissa L. Thompson
    HOSPITAL PHARMACY, 2019, 54 (03) : 160 - 164
  • [5] Acute hepatotoxicity after high-dose cytarabine for the treatment of relapsed acute myeloid leukemia: a case report
    Fu, Samuel
    Flannery, Alexander
    Bastin, Melissa
    PHARMACOTHERAPY, 2017, 37 (12): : E227 - E227
  • [6] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
    Lowenberg, Bob
    BLOOD, 2013, 121 (01) : 26 - 28
  • [7] Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia
    Schlenk, Richard F.
    HAEMATOLOGICA, 2024, 109 (06) : 1629 - 1630
  • [8] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [9] High-dose cytarabine, etoposide and cisplatin salvage chemotherapy for relapsed adult acute myeloid leukemia.
    Lee, JS
    Lee, KW
    Lee, WS
    Kim, J
    Yoon, SS
    Park, S
    Kim, BK
    BLOOD, 2003, 102 (11) : 230B - 230B
  • [10] Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Zeidner, Joshua F.
    Vincent, Benjamin G.
    Ivanova, Anastasia
    Moore, Dominic
    McKinnon, Karen P.
    Wilkinson, Alec D.
    Mukhopadhyay, Rupkatha
    Mazziotta, Francesco
    Knaus, Hanna A.
    Foster, Matthew C.
    Coombs, Catherine C.
    Jamieson, Katarzyna
    Van Deventer, Hendrik
    Webster, Jonathan A.
    Prince, Gabrielle T.
    DeZern, Amy E.
    Smith, B. Douglas
    Levis, Mark J.
    Montgomery, Nathan D.
    Luznik, Leo
    Serody, Jonathan S.
    Gojo, Ivana
    BLOOD CANCER DISCOVERY, 2021, 2 (06): : 616 - 629
12345